Methodology

1. Introduction

The Aesthetic & Men's Health Practice Calculator publishes pricing, cost, time, retention, and ramp data for 35 procedures spanning aesthetic medicine (neuromodulators, fillers, body sculpting, skin resurfacing) and men's health (penile filler, penile botox, GentShot, shockwave) across 51 states and 50 metros. Its purpose is to give practice owners, analysts, and journalists a defensible starting point for revenue modeling — not a marketing tool.

Standards GentsMed holds itself to: every published number traces to a public source or a disclosed clinic-data aggregation. Every assumption is on-screen, not buried in code. Every change to the data is a versioned commit. Where sources disagree, the calculator surfaces the disagreement.

Cosmetic-urology procedure data (penile filler, penile botox / UroFirm) is calibrated against anonymized aggregated data from a 23-location men's-health clinical network. Specifics in §10.

2. Data sources

22primary sources, organized below by kind. Each is referenced by a stable ID throughout the calculator's data files; the per-procedure source list on every procedure page maps to this bibliography.

Full bibliography is at the bottom of this page. Source IDs appear inline on every procedure, regional, and pricing breakdown.

3. Pricing methodology

3.1 National average derivation

Three-point range (low, mid, high) triangulating ASPS, AmSpa, and trade-press surveys. Where sources disagree, the calculator favors AmSpa for med-spa procedures and ASPS for surgical-adjacent ones. Per-procedure source list is on each procedure's page.

3.2 Regional multipliers

Tier classification is by MSA population (Census 2024): tier-1 metros (top 25 by MSA pop), tier-2 (next 25), tier-3 (next 50), rural (remainder). Multipliers come from MERIC COLI plus AmSpa density data. State-level overrides are applied where evidence is strong (e.g. California across the board, Texas urban corridors).

3.3 Update cadence

Pricing is refreshed annually after ASPS/AmSpa annual report publication (typically Q2). Out-of-cycle updates run when manufacturer pricing or compounded-availability rules change materially (e.g. semaglutide compounded-pharmacy rules in 2025).

4. Cost of goods methodology

Manufacturer wholesale pricing is not publicly disclosed at unit level. COGS values are derived from trade-press reported volume-tier pricing, public investor disclosures of segment revenue divided by published unit growth, and calibration against the clinic-data network's procurement data where applicable.

COGS excludes amortized equipment (modeled separately under capital_investment) and staff time (modeled separately under provider time).

4a. Procurement-rate model for HA filler (UroSculpt™ protocol)

The calculator separates two orthogonal axes for HA filler:

1. Procedure size / volume band — set by patient anatomy and treatment goal. Typical per-procedure volumes: 6 mL (low), 12 mL (mid), 15 mL (high).
2. Procurement tier— set by the practice's purchasing relationship. Three tiers are modeled (see table below).

Per-procedure COGS = volume × per-mL rate. The calculator surfaces all three tiers so a reader can self-identify and see corresponding economics. Default tier is retail (most-conservative). Selecting loyalty or network quantifies the tier benefit as a dollar delta.

Other manufacturer-supplied products (Botox, Sculptra, Radiesse) have narrower per-unit price spreads (~10–25%) and are modeled with a single industry-typical COGS range rather than explicit tiers.

4b. Revenue-side effects of certification

The calculator does not automatically apply revenue uplift when the procurement tier is set to network. Revenue inputs (new-patient volume and price band) stay user-controlled. Blending procurement and revenue effects into one tier toggle would make the output non-attributable.

A separate certification-progression panel (visible when penile-filler is in the selection) decomposes the full ROI into 4 transparent steps, each changing exactly one variable: independent baseline, + rep relationship, + brand pricing authority, + UroSculpt™ certification with directory routing.

5. Time and capacity methodology

Procedure minutes are net in-chair minutes, not full appointment length. Prep minutes are captured separately. Where procedures require materially longer appointment time for new patients (e.g. penile filler: 90 min new-patient vs 45 min returning), the calculator carries both values and weights them by the new-patient fraction implied by the ramp curve.

Capacity = provider available hours × 60 ÷ (weighted procedure minutes + prep). The capacity-utilization warning fires when planned volume × per-procedure time exceeds 85% of available provider time.

6. Ramp curves

Ramp curves model new-practice or new-procedure adoption. High-demand procedures (botox, semaglutide, laser hair removal) ramp fastest (≥50% of mature volume by month 3). Capital-intensive devices ramp slowest (<25% by month 3). Mature volume = month-24 baseline; not every practice reaches mature.

7. Patient retention and LTV

Retention is modeled per-procedure rather than per-practice (practices retain patients in aggregate even when individual procedure attach rate fades). Y1/Y2/Y3 retention fractions come from AmSpa retention surveys, calibrated against the clinic-data network's longitudinal data for cosmetic-urology procedures.

8. Marketing cost of acquisition

Channel-specific ranges (paid ads, organic, referral) sourced from PatientGain industry benchmarks. Premium procedures show wider CAC ranges (lower volume → higher per-patient ad spend). Referral CAC is non-zero when referral programs include payment.

9. Provider scope of practice

Per-procedure list of provider types authorized to perform under typical practice protocols (RN, NP, PA, MD, DO). State-specific supervision notes for procedures and states where scope materially differs. Sourced from NCSBN APRN database and individual state nursing/medical boards.

Scope rules change frequently; calculator displays current as of access date with refresh on annual review.

10. Clinic data disclosure

The calculator's cosmetic-urology procedure data (penile filler, penile botox / UroFirm) is calibrated against anonymized aggregated data from a 23-location men's-health clinical network. No location-level data is exposed in this calculator. Published values are tier-bucketed national averages.

Specific data categories sourced from clinic data:

• Pricing (national average + tier multipliers)
• Cost of goods at scale procurement
• Procedure time benchmarks (new-patient vs returning-patient)
• Repeat cadence
• Year-1 / Year-2 / Year-3 retention fractions
• Marketing CAC by channel
• Ramp curve for new-location procedure launches
• First-year startup overhead estimates for adding the program

No public industry benchmark exists for cosmetic urology at scale, so the network's data is the primary source for these categories.

Important limitations of the network's data

• Single-brand sample.The network operates under a unified brand. Pricing strategy, acquisition channels, and operational protocols are correlated, not independent samples. Practices with different brand positioning, target demographics, or marketing maturity will see different economics — possibly in either direction.
• New-patient revenue tracked precisely; returning-patient revenue inferred. Returning-patient cadence is inferred from appointment scheduling rather than transactional data. Retention fractions are best-effort estimates calibrated against publicly available benchmarks (AmSpa) where direct measurement is imprecise.
• Broad revenue distribution. Locations range from ~$6,000/mo total cosmetic-urology revenue (low end, newer or smaller-market) to ~$80,000/mo (high end, mature locations in major metros). The ramp curve targets the median-to-upper-quartile maturity case; individual practices may significantly under- or over-perform.
• New-patient volume reference points.Mature high-volume locations see ~6–7 new cosmetic-urology patients/mo with average first-visit spend near $7,000; mature low-volume locations see ~1/mo at similar spend. This range bounds the realistic per-location output that mid-case calculator results target.

11. Limitations and disclaimers

• Individual practice results vary significantly based on local competition, demographics, marketing skill, provider experience, payor mix, and dozens of factors not captured here.
• This tool is a planning aid, not financial advice. Numbers should not be used as the sole basis for any business decision, loan application, or investor pitch.
• The calculator does not model overhead, rent, payroll, malpractice insurance, EMR cost, or other practice operating expenses.
• For comprehensive financial modeling, consult a CPA experienced in aesthetic medical practices.
• GentsMed, its affiliates, contributors, and the publisher disclaim liability for outcomes based on use of this tool.

12. Corrections and feedback

Spotted a data error, broken citation, or out-of-date scope-of-practice rule? Email [email protected]. Substantive corrections are reviewed promptly and result in a methodology update entry with re-publication.

13. Bibliography

Full source list referenced by the calculator. Source IDs are cited on every procedure, regional, and pricing breakdown page.